[18F]FES PET/CT in Endocrine Refractory Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor Positive Breast Cancer|Breast Neoplasm|Metastatic Breast Cancer
Interventions: DRUG: [18F]FES
Sponsor: University of Pennsylvania